BlueStone Venture Partners
BlueStone Venture Partners is a venture capital firm established in 2018, initially launched in Tucson, Arizona, and currently based in Santa Fe, New Mexico. The firm specializes in providing strategic capital and support to early-stage life science companies, primarily focusing on Series A and Series B funding rounds. Its investment interests encompass a range of sectors, including medical devices, health information technology, advanced materials, molecular diagnostics, and biopharma. The firm aims to foster innovation and growth within these industries by partnering with entrepreneurial companies.
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Arizona
GT Medical Technologies
Series C in 2023
GT Medical Technologies develops and manufactures a novel medical device for treating brain tumors. Its flagship product, GammaTile™, combines a conformable collagen matrix with brachytherapy seeds to deliver targeted radiation therapy, potentially revolutionizing treatment for over 176,000 patients annually in the U.S. The company's focus is improving patient outcomes and quality of life.
GT Medical Technologies
Series B in 2020
GT Medical Technologies develops and manufactures a novel medical device for treating brain tumors. Its flagship product, GammaTile™, combines a conformable collagen matrix with brachytherapy seeds to deliver targeted radiation therapy, potentially revolutionizing treatment for over 176,000 patients annually in the U.S. The company's focus is improving patient outcomes and quality of life.
Pyx Health
Series A in 2020
Founded in 2017, Pyx Health is a healthcare technology company based in Tucson, Arizona. It develops a mobile solution that connects with members outside traditional care settings to reduce loneliness and social isolation. The platform combines artificial intelligence and human interventions for timely health interventions, addressing social determinants of health.
GT Medical Technologies
Series A in 2019
GT Medical Technologies develops and manufactures a novel medical device for treating brain tumors. Its flagship product, GammaTile™, combines a conformable collagen matrix with brachytherapy seeds to deliver targeted radiation therapy, potentially revolutionizing treatment for over 176,000 patients annually in the U.S. The company's focus is improving patient outcomes and quality of life.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.